Etravirine Tablet — FDA Drug Shortage

To Be Discontinued — Janssen Research And Development

The FDA lists a drug shortage record for Etravirine Tablet (tablet) from Janssen Research And Development with status To Be Discontinued. The shortage was first posted on Apr 28, 2026.

Shortage details

Status
To Be Discontinued
Company
Janssen Research And Development
Package NDC
59676-570-01
Dosage Form
Tablet
Presentation
Intelence, Tablet, 100 mg (NDC 59676-570-01)
Initial Posting
Apr 28, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.